FDA Asks Institute Of Medicine To Evaluate 510(k) Review Process
This article was originally published in The Gray Sheet
Executive Summary
FDA has commissioned the Institute of Medicine to assess its 510(k) pre-market review process for medical devices and help determine how the oft-criticized program can be improved, the agency announced Sept. 23